环磷酰胺处理小鼠的呼吸道疾病。II. PR8流感病毒毒力降低
Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.
作者信息
Singer S H, Noguchi P, Kirschstein R L
出版信息
Infect Immun. 1972 Jun;5(6):957-60. doi: 10.1128/iai.5.6.957-960.1972.
Abstract
Mice infected intranasally with the PR8 strain of influenza virus were treated with cyclophosphamide, a potent immunologic suppressor. During the first week of infection, mortality in the unmodified influenza infection averaged 65%, whereas in those animals also treated with cyclophosphamide it averaged 22.5%. After the first week, the mortality rate in the infected cyclophosphamide-treated animals rose to that seen during the first week in the animals only infected. This decreased mortality in the first week was found despite the fact that the cyclophosphamide-treated and infected animals had higher virus titers which persisted longer, decreased circulating antibody, and a decreased interferon response. This delayed mortality appeared to be related to the finding of decreased cellular infiltration in the lungs of infected cyclophosphamide-treated animals.
摘要
用环磷酰胺（一种强效免疫抑制剂）对经鼻内感染流感病毒PR8株的小鼠进行治疗。在感染的第一周，未接受治疗的流感感染小鼠的死亡率平均为65%，而在同时接受环磷酰胺治疗的小鼠中，死亡率平均为22.5%。第一周后，接受环磷酰胺治疗的感染动物的死亡率上升至仅感染动物在第一周时的死亡率。尽管接受环磷酰胺治疗并感染的动物病毒滴度更高且持续时间更长、循环抗体减少以及干扰素反应降低，但仍发现第一周死亡率降低。这种延迟的死亡率似乎与在接受环磷酰胺治疗并感染的动物肺部发现细胞浸润减少有关。
相似文献
1
Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.环磷酰胺处理小鼠的呼吸道疾病。II. PR8流感病毒毒力降低
Infect Immun. 1972 Jun;5(6):957-60. doi: 10.1128/iai.5.6.957-960.1972.
2
Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis.环磷酰胺处理小鼠的呼吸道疾病。I. 肺支原体毒力增强。
Infect Immun. 1972 Jun;5(6):953-6. doi: 10.1128/iai.5.6.953-956.1972.
3
The spread and persistence of influenza viruses in normal and cyclophosphamide-treated mice.
J Med Virol. 1981;7(4):251-62. doi: 10.1002/jmv.1890070402.
4
Depression of early protection against influenza virus infection by cyclophosphamide and its restoration by protein-bound polysaccharide.环磷酰胺对流感病毒感染早期保护作用的抑制及其被蛋白结合多糖恢复的情况。
Kitasato Arch Exp Med. 1992 Sep;65(2-3):97-110.
5
Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus.环磷酰胺对由强毒株和无毒株流感病毒引起的小鼠感染的影响。
Infect Immun. 1975 May;11(5):886-9. doi: 10.1128/iai.11.5.886-889.1975.
6
Effect of chlorite-oxidized oxyamylose on influenza virus infection in mice.亚氯酸盐氧化直链淀粉对小鼠流感病毒感染的影响。
Appl Microbiol. 1971 Apr;21(4):580-4. doi: 10.1128/am.21.4.580-584.1971.
7
The role of neutrophils during mild and severe influenza virus infections of mice.中性粒细胞在小鼠轻度和重度流感病毒感染中的作用。
PLoS One. 2011 Mar 14;6(3):e17618. doi: 10.1371/journal.pone.0017618.
8
The relationship between interferon and virus virulence in influenza virus infections of the mouse.
J Med Microbiol. 1973 Feb;6(1):21-32. doi: 10.1099/00222615-6-1-21.
9
Dynamics of viral growth, viral enzymatic activity, and antigenicity in murine lungs during the course of influenza pneumonia.流感肺炎病程中鼠肺内病毒生长、病毒酶活性及抗原性的动态变化
J Med Virol. 1984;14(2):81-90. doi: 10.1002/jmv.1890140202.
10
Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain.经口用A2流感病毒免疫的小鼠对致病性毒株鼻内攻击的抵抗力。
Acta Virol. 1973 Jul;17(4):298-304.
引用本文的文献
1
Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus.不同药物组合对感染甲型H3N2流感病毒的免疫缺陷小鼠的影响。
Microorganisms. 2020 Dec 11;8(12):1968. doi: 10.3390/microorganisms8121968.
2
Influenza Virus Infection of Human Lymphocytes Occurs in the Immune Cell Cluster of the Developing Antiviral Response.流感病毒感染人类淋巴细胞发生在抗病毒反应发展的免疫细胞簇中。
Viruses. 2018 Aug 10;10(8):420. doi: 10.3390/v10080420.
3
Pathogenicity of pandemic H1N1 influenza A virus in immunocompromised cynomolgus macaques.免疫功能低下食蟹猴感染大流行 H1N1 流感病毒的致病性。
PLoS One. 2013 Sep 23;8(9):e75910. doi: 10.1371/journal.pone.0075910. eCollection 2013.
4
Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.重复静脉注射帕拉米韦对抗免疫抑制小鼠感染甲型 H1N1 流感病毒的疗效。
Antimicrob Agents Chemother. 2013 May;57(5):2286-94. doi: 10.1128/AAC.02324-12. Epub 2013 Mar 11.
5
Screening monoclonal antibodies for cross-reactivity in the ferret model of influenza infection.在雪貂流感感染模型中筛选具有交叉反应性的单克隆抗体。
J Immunol Methods. 2008 Jul 20;336(1):71-7. doi: 10.1016/j.jim.2008.04.003. Epub 2008 Apr 28.
6
CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanisms.CD59a缺乏通过补体依赖性和非依赖性机制加剧流感诱导的肺部炎症。
Eur J Immunol. 2007 May;37(5):1266-74. doi: 10.1002/eji.200636755.
7
Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.Toll样受体（TLR）3对甲型流感病毒诱导的急性肺炎的有害作用。
PLoS Pathog. 2006 Jun;2(6):e53. doi: 10.1371/journal.ppat.0020053. Epub 2006 Jun 9.
8
Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice.抗巨噬细胞炎性蛋白2抗体对小鼠流感病毒诱导性肺炎的治疗作用
J Virol. 2000 Mar;74(5):2472-6. doi: 10.1128/jvi.74.5.2472-2476.2000.
9
The effect of leukocyte depletion on pulmonary M2 muscarinic receptor function in parainfluenza virus-infected guinea-pigs.白细胞去除对副流感病毒感染的豚鼠肺M2毒蕈碱受体功能的影响。
Br J Pharmacol. 1994 Jun;112(2):588-94. doi: 10.1111/j.1476-5381.1994.tb13115.x.
10
The effects of ozone on immune function.臭氧对免疫功能的影响。
Environ Health Perspect. 1995 Mar;103 Suppl 2(Suppl 2):77-89. doi: 10.1289/ehp.95103s277.
本文引用的文献
1
Role of interferon in recovery from virus infections.干扰素在病毒感染恢复过程中的作用。
Lancet. 1960 Jul 9;2(7141):69-71. doi: 10.1016/s0140-6736(60)91215-0.
2
Suppression of influenza viral pneumonia in mice by the non-specific action of xerosin.
J Immunol. 1955 Dec;75(6):430-40.
3
Suppression of viral pneumonia in mice by a microbial product (APM).一种微生物产物（APM）对小鼠病毒性肺炎的抑制作用。
Proc Soc Exp Biol Med. 1952 Aug-Sep;80(4):710-4. doi: 10.3181/00379727-80-19739.
4
Pneumonia due to mycoplasma in gnotobiotic mice. II. Localization of Mycoplasma pulmonis in the lungs of infected gnotobiotic mice by electron microscopy.悉生小鼠支原体肺炎。II. 用电子显微镜观察肺炎支原体在感染悉生小鼠肺内的定位
J Bacteriol. 1966 Oct;92(4):1164-76. doi: 10.1128/jb.92.4.1164-1176.1966.
5
Recovery from primary infection with Langat E5 virus in normal and cyclophosphamide treated mice: relative roles of virus multiplication, interferon, antibody and serum protective factor.正常小鼠和环磷酰胺处理小鼠感染兰加特E5病毒原发性感染后的恢复：病毒增殖、干扰素、抗体和血清保护因子的相对作用
Am J Epidemiol. 1969 May;89(5):593-605. doi: 10.1093/oxfordjournals.aje.a120972.
6
Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide.免疫抑制剂量的环磷酰胺对实验性虫媒病毒脑炎的增强作用。
Nature. 1968 Oct 26;220(5165):399-401. doi: 10.1038/220399a0.
7
Effectiveness of an interferon stimulator in immunosuppressed mice.
Proc Soc Exp Biol Med. 1971 Feb;136(2):349-53. doi: 10.3181/00379727-136-35262.
8
9
Respiratory diseases in cyclophosphamide-treated mice. I. Increased virulence of Mycoplasma pulmonis.环磷酰胺处理小鼠的呼吸道疾病。I. 肺支原体毒力增强。
Infect Immun. 1972 Jun;5(6):953-6. doi: 10.1128/iai.5.6.953-956.1972.
10
Fatal Japanese encephalitis virus infection in immunosuppresed spider monkeys.免疫抑制蜘蛛猴的致命性日本脑炎病毒感染
Clin Exp Immunol. 1970 Jan;6(1):161-6.
Zotero 插件